Skip to content
CityAM
Main navigation
Sign Up
  • News
    • Latest News
    • Property
    • Business
    • Media
    • Technology
    • Retail and leisure
    • Transport and infrastructure
    • Law & professional services
    • Legal Notices
    • Banking
    • Politics
    • CFA Institute Talk
    • ICAS Talk
    • Warwick Business School
    • The University of Bath
    • AON
  • Markets & Economics
    • Markets & Economics News
    • Economics
    • Markets
    • Schroders Talk
    • eToro Talk
    • IG Talk
    • M&A Talk
    • BCB Talk
  • Crypto A.M.
    • Crypto News
    • CoinCorner Talk
    • Crypto Magazine
  • Opinion
    • Features
    • Letters
    • The City View
  • Jobs and Money
    • Jobs and Money News
    • Personal Development
    • Jobs
    • Fintech
    • Money
    • Personal Finance
    • Doceo
    • The Business Guide
    • 10 ways to run a more efficient business
    • Finance & Legal
  • Unwind
    • Unwind
    • Sport
    • Six Nations 2022
    • The Punter
    • The Punter Podcast
    • Culture
    • Life & Style
    • Sport Business
    • The Magazine
    • Travel
    • Discover Malta
    • Green Economy
    • The DiverCity Podcast
    • Aramco Team Series
    • Queen’s Award 2022
    • Health, Fitness, and Wellbeing
  • Charity
    • Giving
    • World’s biggest donors 2010 – 2021
  • Latest Paper
  • Jobs

AstraZeneca

  • Oxford Biomedica extends deal with AstraZeneca to make Covid vaccines beyond 2022

    vaccines

    Oxford Biomedica have inked a new three-year agreement to make AstraZeneca's COVID-19 vaccine beyond 2022.

  • NHS agrees to pay £120k in damages to bereaved fiancee in covid first

    Covid Vaccine

    A woman whose fiance died after taking the covid jab has claimed to have received the first covid vaccine damage payment of £120,000.

  • AstraZeneca injects further £100m in Cambridge research centre

    AstraZeneca

    AstraZeneca injects another £100m over budget to complete its Cambridge-based research and development centre. The Discovery Centre, or the ‘Disc’ as it is also known, was formally unveiled in November by Prince Charles and business secretary Kwasi Kwarteng. According to The Times, the site has cost the vaccine-maker £1.1bn, which is more than three times [...]

  • Astra Zeneca revenues jump over 40 per cent amid vaccine rollout

    February 10, 2022

    Revenues at Astra Zeneca have risen 41 per cent, with Covid-19 vaccine sales boosting its performance across the year.

  • Pfizer accused of funding anti-AstraZeneca information

    December 5, 2021

    US drugmaker Pfizer, the world’s dominant Covid vaccine maker, has been accused of funding educational presentations that said its UK rival AstraZeneca was ineffective and even dangerous for some members of the population. A Channel 4 Dispatches investigation due to be broadcast this week says it has “uncovered evidence” that Pfizer funded a number of [...]

  • UK scientists discover what causes blood clot complications in AstraZeneca Covid vaccine

    December 2, 2021

    UK scientists believe they have found the reason behind the extremely rare blood clot complications stemming from the Oxford/AstraZeneca vaccine. According to an international team of researchers from Cardiff and the US, the reaction can be traced to the way the adenovirus used by the vaccine to shuttle the coronavirus’ genetic material into cells binds [...]

  • ‘Don’t freak out’: Vaccine bosses attempt to diffuse Omicron-induced jab fears 

    November 30, 2021

    Vaccine leaders have rushed to put out the fires of Moderna CEO’s jab cautions, urging the world: “Don’t freak out”.  Pharmaceutical heavyweights have been gathering data on the latest Covid-19 variant Omicron, as concerns swell that a tailor-made vaccine may be necessary. AstraZeneca is already researching locations where the variant has been identified, namely in [...]

  • AstraZeneca opens new £1bn research fortress in Cambridge for army of 2,200 scientists

    November 25, 2021

    AstraZeneca has officially opened The Discovery Centre (DISC) in Cambridge, its newest research and development facility which will swing open its doors to 2,200 research scientists from today. The new £1bn facility will include robotics, high-throughput screening and AI-driven technology. It will support AstraZeneca’s focus on specialised and precision medicines and foster the discovery and [...]

  • Covid-19 global pandemic to be ‘regional epidemic’ by next year, says AstraZeneca boss

    November 23, 2021

    AstraZeneca boss Pascal Soriot said that he expects the global Covid-19 pandemic to become a regional epidemic by next year, after the pharmaceutical giant decided to start profiting from its vaccine. The chief executive of the pharmaceutical giant told Sky News that by 2022, “essentially most of the world at that point will be in [...]

  • AstraZeneca sales jump 50 per cent as vaccine crawls to profitability

    November 12, 2021

    AstraZeneca’s revenues have soared 32 per cent this year to $25.4bn, powered by booming product sales. Third quarter revenues are up 50 per cent, with the pharmaceutical giant enjoying a $9.87 billion increase in revenues over the three-month period. The company has sold 2.2 billion vaccines since the start of the year. It has now [...]

Posts navigation

  • Page 1
  • Page 2
  • Page 3
  • …
  • Page 18
  • Next

Trending Articles

  • Kremlin orders seizure of gas facility which Shell has 27 per cent stake in worth £3.4bn

  • Brits to face further travel woes as airlines prepare to announce fresh wave of cancelled flights

  • Boris Johnson mulls 50-year mortgages to get more young people on housing ladder

  • Boost for Global Britain as UK exports to EU defy Brexit challenges and hit highest level ever

Subscribe

Subscribe to the City A.M. newsletter to have our top stories delivered directly to your inbox.

Subscribe
  • About us
  • Advertising
  • Contact
  • Terms & Conditions
  • Privacy Policy
  • News
  • Markets & Economics
  • Opinion
  • Jobs and Money
  • Unwind
  • Crypto A.M.
  • The Punter
  • COP 26
  • Awards 2019

Follow us for breaking news and latest updates

  • Newsletters
  • Latest paper
  • Advertising
  • CryptoAM.io
  • Awards
  • About
  • Tickets
Copyright 2022 City A.M. Limited